CCPN SPAF Tool vs SPARCtool

Stroke prevention for your patients with atrial fibrillation The Canadian Cardiovascular Pharmacist Network (CCPN) SPAF Tool App is designed to assist Canadian healthcare professionals optimize stroke prevention treatment in their patients with nonvalvular atrial fibrillation. It was modeled after the CCPN SPAF pocket card. It incorporates stroke risk stratification using CHADS and CHADSVASc criteria, bleeding risk using HAS-BLED criteria and provides recommendations for stroke prevention therapy based on the Canadian Cardiovascular Society (CCS) AFIB Guidelines. This app also includes practical drug information, dose recommendations, creatinine clearance calculations, and management tools which allow healthcare professionals to compare therapeutic options and tailor therapy for individual patients. It is intended as a general reference to supplement the existing knowledge of healthcare professionals. This app was supported in kind by the Centre for Innovation in Complex Care (CICC) and through an unrestricted grant from the Pfizer-Bristol Myers Squibb Alliance and Servier Canada. The original CCPN SPAF pocket card was supported through an unrestricted grant from Boehringer Ingelheim Canada 

For use by Canadian healthcare professionals only.

SPARCtool (Stroke Prevention in Afib Risk Calculator) is a clinical decision-support and educational tool to support informed conversations about stroke prevention in patients with atrial fibrillation. Enter patient risk factors to instantly calculate CHA₂DS₂-VASc and HAS-BLED scores. SPARCtool then transforms these scores into an intuitive visual comparison of the patient’s individualized annual risks of stroke and major bleeding across all antithrombotic treatment options. Features: • Individualized comparisons of antithrombotic therapy options • Annual stroke and major bleeding risk estimates • Treatment trade-off (Net Clinical Benefit) estimates • 100-person faces grids (risk pictures) • Therapy-specific cautions depending on patient attributes • Selected therapy options are retained on device between uses • References and explanatory notes • Shareable PDF results • Copyable EMR summary Beginning in 2003 as a Palm Pilot™ app, and since 2013 as a web app (www.sparctool.com), SPARCtool has been supporting clinicians and patients worldwide to have informed conversations about stroke prevention treatment decisions. SPARCtool is regularly updated to reflect current evidence about therapy options. Calculations occur locally on the device. SPARCtool does not collect or transmit patient information. SPARCtool supports learning and informed clinical conversations. It does not replace clinical judgment, individualized professional advice, or consideration of current clinical guidelines and product information. The author of SPARCtool has no relationship with sponsors or other industry interests involving atrial fibrillation or its therapies.